SCHEMBL7335463

SCHEMBL7335463

CC1CC(=O)NN=C1c1ccc(OCCCNCC(O)COc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.54
ATM Q13315 1/20 0.51
ADRB2 P07550 2/20 0.50
ADRB1 P08588 2/20 0.50
ADRB3 P13945 2/20 0.50
CYP1A2 P05177 1/20 0.50
PDE3B Q13370 3/20 0.47
PDE3A Q14432 3/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
GPR119 Q8TDV5 1/20 0.44
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
MEN1 O00255 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328370 0.86 HRH3 (0.47) HRH3ATMADRB2ADRB1ADRB3
SCHEMBL7299789 0.85 ADRB1 (0.49) HRH3ADRB2ADRB1ADRB3CYP1A2
SCHEMBL7305182 0.85 HRH3 (0.46) HRH3ATMADRB2ADRB1ADRB3
SCHEMBL7304714 0.81 HRH3 (0.46) HRH3ATMADRB2ADRB1ADRB3
SCHEMBL7306614 0.81 ADRB1 (0.52) HRH3ATMADRB2ADRB1ADRB3
SCHEMBL9686104 0.80 HRH3 (0.43) HRH3ATMADRB2ADRB1ADRB3
SCHEMBL7329284 0.79 GPR119 (0.45) ADRB2ADRB1ADRB3CYP1A2CYP2D6
SCHEMBL7303501 0.78 ADRB1 (0.49) ADRB2ADRB1ADRB3CYP1A2GPR119
SCHEMBL7303255 0.78 GPR119 (0.42) ATMADRB2ADRB1ADRB3CYP1A2
SCHEMBL7325070 0.77 CYP3A4 (0.48) ATMADRB2ADRB1ADRB3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5204463-A Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities GLAXO INC. (US) 1993-04-20 US disclosed
US-5096904-A Congestive heart failure GLAXO INC. (US) 1992-03-17 US disclosed
US-5053338-A Hydrolysis of ester to obtain an optically enriched mixture of a phenol enantiomer GLAXO INC. (US) 1991-10-01 US disclosed
EP-0412814-A2 Pyridazinones having cardiotonic and beta blocking activity GLAXO WELLCOME INC. (US) 1991-02-13 EP disclosed